SCHEMBL32688110

SCHEMBL32688110

CNC(=O)c1c(-c2ccc(Cl)cc2)c(C#N)c(SCc2nnn[nH]2)[nH]c1=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.38
▸ HSD11B1 P28845 2/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ LDHA P00338 7/20 0.37
▸ ACMSD Q8TDX5 1/20 0.36
▸ HPGD P15428 2/20 0.36
▸ LDHB P07195 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ TP53 P04637 2/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688263 0.89 ACMSD (0.42) MAPTHSD11B1KMT2AALDH1A1LMNA
SCHEMBL32688362 0.88 HSD11B1 (0.39) MAPTHSD11B1KMT2AALDH1A1LMNA
SCHEMBL32688127 0.88 MAPT (0.45) MAPTKMT2AALDH1A1LDHAHPGD
SCHEMBL32688422 0.88 MAPT (0.38) MAPTHSD11B1KMT2AALDH1A1LMNA
SCHEMBL32688022 0.86 ALDH1A1 (0.52) MAPTHSD11B1KMT2AALDH1A1LMNA
SCHEMBL32688269 0.84 HSD11B1 (0.45) HSD11B1KMT2AALDH1A1LMNALDHA
SCHEMBL32688001 0.83 CUL4A (0.49) MAPTHSD11B1KMT2AALDH1A1LMNA
SCHEMBL32688235 0.83 HSD11B1 (0.45) HSD11B1KMT2AALDH1A1LMNALDHA
SCHEMBL32688250 0.78 HSD11B1 (0.41) HSD11B1KMT2ALMNAACMSDPOLB
SCHEMBL32688034 0.77 PDE9A (0.43) KMT2APOLBKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK MAPT 4018/4885HSD11B1 61/4885KMT2A 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback